Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation (Q33392218)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation
scientific article

    Statements

    Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation (English)
    Lindsay L Rosenbeck
    Patrick J Kiel
    Iftekhar Kalsekar
    Cheryl K Sullivan
    Sahar Abdelqader
    Shivani Srivastava
    Rafat Abonour
    Michael J Robertson
    Robert P Nelson
    Kenneth Cornetta
    Christopher A Fausel
    Sherif S Farag
    4 December 2010

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit